Published in Am J Epidemiol on August 01, 1989
Coffee, tea and caffeine consumption in relation to osteoporotic fracture risk in a cohort of Swedish women. Osteoporos Int (2006) 1.26
Increased risk of left sided colon cancer in patients with diverticular disease. Gut (1993) 1.24
Time trends of age-adjusted incidence rates of first hip fractures: a register-based study among older people in Viborg County, Denmark, 1987-1997. Osteoporos Int (2006) 1.19
Scleroderma and malignancy: an epidemiological study. Ann Rheum Dis (1993) 1.14
Male risk factors for hip fracture-a 30-year follow-up study in 7,495 men. Osteoporos Int (2009) 1.13
Physical activity and predisposition for hip fractures: a review. Osteoporos Int (1997) 1.08
Prevalence of osteoporosis and incidence of hip fracture in women--secular trends over 30 years. BMC Musculoskelet Disord (2010) 0.92
Direct-to-participant feedback and awareness of bone mineral density testing results in a population-based sample of mid-aged Canadians. Osteoporos Int (2009) 0.83
Dietary calcium, sex hormones, and bone mineral density in men. BMJ (1990) 0.83
Gastric cancer risk after vagotomy. Gut (1994) 0.82
Maternal age, exposure to siblings, and risk of amyotrophic lateral sclerosis. Am J Epidemiol (2008) 0.79
Educational level and use of osteoporosis drugs in elderly men and women: a Swedish nationwide register-based study. Osteoporos Int (2012) 0.78
Re: "Time trends in incidence rates of first hip fracture in the Uppsala Health Care Region, Sweden, 1965-1983". Am J Epidemiol (1990) 0.75
Bone T-scores and functional status: a cross-sectional study on German elderly. PLoS One (2009) 0.75
A turnover pathway for both stable and unstable mRNAs in yeast: evidence for a requirement for deadenylation. Genes Dev (1993) 9.28
A rapid method for localized mutagenesis of yeast genes. Yeast (1992) 7.79
Deadenylation of the unstable mRNA encoded by the yeast MFA2 gene leads to decapping followed by 5'-->3' digestion of the transcript. Genes Dev (1994) 7.57
Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med (1990) 6.87
Degradation of mRNA in eukaryotes. Cell (1995) 6.81
An essential component of the decapping enzyme required for normal rates of mRNA turnover. Nature (1996) 6.15
Recognition of the TACTAAC box during mRNA splicing in yeast involves base pairing to the U2-like snRNA. Cell (1987) 6.08
Premature translational termination triggers mRNA decapping. Nature (1994) 6.05
Yeast Sm-like proteins function in mRNA decapping and decay. Nature (2000) 5.95
The transcription factor associated Ccr4 and Caf1 proteins are components of the major cytoplasmic mRNA deadenylase in Saccharomyces cerevisiae. Cell (2001) 5.86
Turnover mechanisms of the stable yeast PGK1 mRNA. Mol Cell Biol (1995) 5.83
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Identification and comparison of stable and unstable mRNAs in Saccharomyces cerevisiae. Mol Cell Biol (1990) 5.47
The DCP2 protein is required for mRNA decapping in Saccharomyces cerevisiae and contains a functional MutT motif. EMBO J (1999) 5.08
Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol (2000) 4.83
The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81
The DEAD box helicase, Dhh1p, functions in mRNA decapping and interacts with both the decapping and deadenylase complexes. RNA (2001) 4.80
Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst (1993) 4.59
Yeast exosome mutants accumulate 3'-extended polyadenylated forms of U4 small nuclear RNA and small nucleolar RNAs. Mol Cell Biol (2000) 4.57
Mutations in translation initiation factors lead to increased rates of deadenylation and decapping of mRNAs in Saccharomyces cerevisiae. Mol Cell Biol (1999) 4.35
Mechanisms and control of mRNA turnover in Saccharomyces cerevisiae. Microbiol Rev (1996) 4.34
High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA (1992) 4.31
Evidence of prenatal influences on breast cancer risk. Lancet (1992) 4.25
The relation between survival and age at diagnosis in breast cancer. N Engl J Med (1986) 4.21
Mutations affecting stability and deadenylation of the yeast MFA2 transcript. Genes Dev (1992) 4.20
Multiple functions for the poly(A)-binding protein in mRNA decapping and deadenylation in yeast. Genes Dev (1995) 4.15
Targeting an mRNA for decapping: displacement of translation factors and association of the Lsm1p-7p complex on deadenylated yeast mRNAs. Mol Cell (2001) 4.12
Transient increase in the risk of breast cancer after giving birth. N Engl J Med (1994) 4.08
Sexually transmitted infection as a cause of anal cancer. N Engl J Med (1997) 4.05
Infections as a major preventable cause of human cancer. J Intern Med (2000) 3.96
A small segment of the MAT alpha 1 transcript promotes mRNA decay in Saccharomyces cerevisiae: a stimulatory role for rare codons. Mol Cell Biol (1993) 3.91
Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA (1997) 3.80
Cohort studies of fat intake and the risk of breast cancer--a pooled analysis. N Engl J Med (1996) 3.79
The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med (1989) 3.77
Quality control of mRNA 3'-end processing is linked to the nuclear exosome. Nature (2001) 3.69
Stressful life events and Graves' disease. Lancet (1991) 3.63
Mutations in trans-acting factors affecting mRNA decapping in Saccharomyces cerevisiae. Mol Cell Biol (1996) 3.58
Parity, age at first childbirth, and risk of ovarian cancer. Lancet (1994) 3.48
Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev (2001) 3.43
Should the mission of epidemiology include the eradication of poverty? Lancet (1998) 3.42
Effect of low-level body burdens of lead on the mental development of children: limitations of meta-analysis in a review of longitudinal data. Arch Environ Health (1992) 3.42
The Puf3 protein is a transcript-specific regulator of mRNA degradation in yeast. EMBO J (2000) 3.38
Differential effects of translational inhibition in cis and in trans on the decay of the unstable yeast MFA2 mRNA. J Biol Chem (1994) 3.37
Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. JAMA (2001) 3.37
Mutations in conserved intron sequences affect multiple steps in the yeast splicing pathway, particularly assembly of the spliceosome. EMBO J (1986) 3.35
Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden. BMJ (1998) 3.34
Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol (1997) 3.10
Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst (1998) 3.10
mRNA decapping in yeast requires dissociation of the cap binding protein, eukaryotic translation initiation factor 4E. Mol Cell Biol (2000) 3.06
Mechanisms of mRNA degradation in eukaryotes. Trends Biochem Sci (1994) 2.96
Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City. N Engl J Med (1987) 2.91
Overweight as an avoidable cause of cancer in Europe. Int J Cancer (2001) 2.88
Isolation and characterization of Dcp1p, the yeast mRNA decapping enzyme. EMBO J (1998) 2.82
Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group. J Natl Cancer Inst (1994) 2.81
Can measurements of IGF-1 and IGFBP-3 improve the sensitivity of prostate-cancer screening? Lancet (2000) 2.75
Mechanisms of mRNA surveillance in eukaryotes. Annu Rev Genet (1999) 2.73
The exosome: a proteasome for RNA? Cell (1999) 2.72
Trends in prostate cancer survival in Sweden, 1960 through 1988: evidence of increasing diagnosis of nonlethal tumors. J Natl Cancer Inst (1996) 2.71
Function of the ski4p (Csl4p) and Ski7p proteins in 3'-to-5' degradation of mRNA. Mol Cell Biol (2000) 2.71
Prevention of premature birth by screening and treatment for common genital tract infections: results of a prospective controlled evaluation. Am J Obstet Gynecol (1995) 2.69
Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet (2000) 2.69
Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel. Biochem Pharmacol (1996) 2.67
Mechanisms and control of mRNA decapping in Saccharomyces cerevisiae. Annu Rev Biochem (2000) 2.66
Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet (2000) 2.65
10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol (1999) 2.64
Age at first birth, parity and risk of breast cancer: a meta-analysis of 8 studies from the Nordic countries. Int J Cancer (1990) 2.61
Changes in tonsillectomy rates associated with feedback and review. Pediatrics (1977) 2.60
Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet (1990) 2.58
A point mutation in the conserved hexanucleotide at a yeast 5' splice junction uncouples recognition, cleavage, and ligation. Cell (1985) 2.56
International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control (1997) 2.52
Strategies for global control of cervical cancer. Int J Cancer (1995) 2.52
The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology (1991) 2.51
Rapid healing of duodenal ulcers with omeprazole: double-blind dose-comparative trial. Lancet (1983) 2.51
The UK colorectal cancer screening pilot: results of the second round of screening in England. Br J Cancer (2007) 2.48
Three conserved members of the RNase D family have unique and overlapping functions in the processing of 5S, 5.8S, U4, U5, RNase MRP and RNase P RNAs in yeast. EMBO J (2000) 2.44
Analysis of the yeast genome: identification of new non-coding and small ORF-containing RNAs. Nucleic Acids Res (1997) 2.40
Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer. Br J Cancer (1999) 2.31
Natural history of cervical neoplasia: consistent results obtained by an identification technique. Br J Cancer (1989) 2.30
Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst (1996) 2.29
Exposure to dioxins as a risk factor for soft tissue sarcoma: a population-based case-control study. J Natl Cancer Inst (1990) 2.22
Cancer risk in patients with diabetes mellitus. Cancer Causes Control (1991) 2.18
Measurement of mRNA decay rates in Saccharomyces cerevisiae. Methods Enzymol (1991) 2.17
Aberrant mRNAs with extended 3' UTRs are substrates for rapid degradation by mRNA surveillance. RNA (1999) 2.15
Functions of Lsm proteins in mRNA degradation and splicing. Curr Opin Cell Biol (2000) 2.14
Survival in breast cancer diagnosed between mammographic screening examinations. Lancet (1986) 2.12
Perinatal measles infection and subsequent Crohn's disease. Lancet (1994) 2.11
Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy. Am J Epidemiol (1989) 2.07
Diversity of cytoplasmic functions for the 3' untranslated region of eukaryotic transcripts. Curr Opin Cell Biol (1995) 2.06
Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst (1997) 2.06
Response rate to mailed epidemiologic questionnaires: a population-based randomized trial of variations in design and mailing routines. Am J Epidemiol (1998) 2.06